펜실베이니아의 림프종 임상 시험
림프종 관련 연구 24개가 펜실베이니아 내 여러 지역에서 참여자를 모집하고 있습니다.
펜실베이니아의 도시
공식 연구 텍스트(영어)
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
피험자 모집 중1/2상
25세 이하 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04094610Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
피험자 모집 중1상
24 Months – 18 Years · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06441331A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- University of Pennsylvania, Philadelphia
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07015242A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07221500Collection of Tissue Samples for Cancer Research
- University of Pittsburgh Medical Center, Pittsburgh
피험자 모집 중관찰 연구
2 Months · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT00900198AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, Philadelphia
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06137144CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
피험자 모집 중1/2상
12 Months – 21 Years · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT04870944A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Thomas Jefferson University, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06624085Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Pittsburgh
피험자 모집 중3상
18세 ~ 18세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07509151TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
- Hospital of the University of Pennsylvania, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07082803Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Lehigh Valley Topper Cancer Center Institute, Allentown
- Thomas Jefferson University, Philadelphia
- West Penn Hospital, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT05826535A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT07192471A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04104776A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Allegheny Health Network, Pittsburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT07188558DALY II USA/ MB-CART2019.1 for DLBCL
- Allegheny Health Network Cancer Institute, Pittsburgh
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 13. 업데이트됨 · NCT04792489Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
- Children's Hospital of Philadelphia, Philadelphia
피험자 모집 중1상
0세 ~ 29세 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT06934382A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT05131022A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site 2, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT05475925Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Hospital of Philadelphia, Philadelphia
피험자 모집 중관찰 연구
0세 ~ 38세 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT06131801Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Saint Christopher's Hospital for Children, Philadelphia
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 5. 18. 업데이트됨 · NCT01790152CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- UPMC Hilman Cancer Center, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT03328078Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- Community Medical Center, Scranton
- 외 1개
피험자 모집 중3상건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 1. 13. 업데이트됨 · NCT05006482CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
- University of Pennsylvania - Abramson Caner Center, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 11. 10. 업데이트됨 · NCT06420089Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- University of Pittsburgh Medical Center (UPMC), Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 9. 22. 업데이트됨 · NCT04234048ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.